Strategies for converting allergens into hypoallergenic vaccine candidates.

[1]  R. Van Ree,et al.  IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance. , 2002, The Journal of allergy and clinical immunology.

[2]  E. Raz,et al.  Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity. , 2002, The Journal of allergy and clinical immunology.

[3]  R. Valenta.  The future of antigen-specific immunotherapy of allergy , 2002, Nature Reviews Immunology.

[4]  R. Valenta,et al.  Specific immunotherapy – the induction of new IgE‐specificities? , 2002, Allergy.

[5]  M. Wills-Karp,et al.  Amb a 1-linked CpG oligodeoxynucleotides reverse established airway hyperresponsiveness in a murine model of asthma. , 2002, The Journal of allergy and clinical immunology.

[6]  Wayne Thomas,et al.  Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  R. Valenta,et al.  Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE‐binding capacity: candidates for grass pollen‐specific immunotherapy , 2002, European journal of immunology.

[8]  R. Valenta,et al.  Intranasal Treatment with a Recombinant Hypoallergenic Derivative of the Major Birch Pollen Allergen Bet v 1 Prevents Allergic Sensitization and Airway Inflammation in Mice , 2001, International Archives of Allergy and Immunology.

[9]  A. Kagey‐Sobotka,et al.  Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. , 2001, The Journal of allergy and clinical immunology.

[10]  M. Luqman,et al.  Antigen-specific T cell tolerance down-regulates mast cell responses in vivo. , 2000, Cellular immunology.

[11]  C. Akdis,et al.  T Cell Epitope-Containing Hypoallergenic Recombinant Fragments of the Major Birch Pollen Allergen, Bet v 1, Induce Blocking Antibodies1 , 2000, The Journal of Immunology.

[12]  F. Spertini,et al.  Inducing Tolerance by Intranasal Administration of Long Peptides in Naive and Primed CBA/J Mice1 , 2000, The Journal of Immunology.

[13]  Oster,et al.  Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild‐type by skin prick and intradermal testing: results obtained in a French population , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  J. Corbeil,et al.  Conjugation of protein to immunostimulatory DNA results in a rapid, long‐lasting and potent induction of cell‐mediated and humoral immunity , 2000, European journal of immunology.

[15]  E. Raz,et al.  Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. , 2000, The Journal of allergy and clinical immunology.

[16]  R. Valenta,et al.  Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen bet v 1 and to recombinant bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients. , 2000, The Journal of allergy and clinical immunology.

[17]  D. Umetsu,et al.  The safety and efficacy of ALLERVAX CAT in cat allergic patients. , 1999, Clinical immunology.

[18]  J. Kinet,et al.  Signalling through the high-affinity IgE receptor FcεRI , 1999, Nature.

[19]  R. Valenta,et al.  Genetically Engineered and Synthetic Allergen Derivatives: Candidates for Vaccination against Type I Allergy , 1999, Biological chemistry.

[20]  Niederberger,et al.  The recombinant allergen‐based concept of component‐resolved diagnostics and immunotherapy (CRD and CRIT) , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  J. Lidholm,et al.  Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy , 1999, European journal of immunology.

[22]  M. Schlaak,et al.  "Allergen engineering": variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity. , 1999, Journal of immunology.

[23]  N. Serizawa,et al.  Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific TH1 and TH2 cell responses in Cry j 2-primed mice. , 1998, The Journal of allergy and clinical immunology.

[24]  Asero.  Effects of birch pollen‐specific immunotherapy on apple allergy in birch pollen‐hypersensitive patients , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  J Bousquet,et al.  Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. , 1998, The Journal of allergy and clinical immunology.

[26]  R. Valenta,et al.  Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations. , 1998, The Journal of allergy and clinical immunology.

[27]  H. Breiteneder,et al.  Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells. , 1998, The Journal of allergy and clinical immunology.

[28]  P. Bhalla,et al.  Engineering of hypoallergenic mutants of the Brassica pollen allergen, Bra r 1, for immunotherapy , 1998, FEBS letters.

[29]  S. Durham,et al.  Immunologic changes associated with allergen immunotherapy. , 1998, The Journal of allergy and clinical immunology.

[30]  M. Suko,et al.  Hyposensitization to allergic reaction in rDer f 2‐sensitized mice by the intranasal administration of a mutant of rDer f 2, C8/119S , 1998, Clinical and experimental immunology.

[31]  C. Akdis,et al.  Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. , 1998, The Journal of allergy and clinical immunology.

[32]  R. Valenta,et al.  IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. , 1998, The Journal of allergy and clinical immunology.

[33]  H. Karjalainen,et al.  Recombinant allergen fragments as candidate preparations for allergen immunotherapy. , 1997, The Journal of allergy and clinical immunology.

[34]  R. Esch,et al.  Allergen source materials and quality control of allergenic extracts. , 1997, Methods.

[35]  D. Richman,et al.  Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.

[36]  A. Mori,et al.  Engineering of the major house dust mite allergen Der f 2 for allergen-specific immunotherapy , 1997, Nature Biotechnology.

[37]  D. Klinman,et al.  Contribution of CpG motifs to the immunogenicity of DNA vaccines. , 1997, Journal of immunology.

[38]  R. Valenta,et al.  Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy. , 1997, The Journal of clinical investigation.

[39]  K. B. Hafner,et al.  Treatment of cat allergy with T-cell reactive peptides. , 1996, American journal of respiratory and critical care medicine.

[40]  Santa Jeremy Ono,et al.  Biology and genetics of atopic disease. , 1996, Current opinion in immunology.

[41]  E. Raz,et al.  Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization , 1996, Science.

[42]  R. Valenta,et al.  Immunological and structural similarities among allergens: Prerequisite for a specific and component‐based therapy of allergy , 1996, Immunology and cell biology.

[43]  R. Valenta,et al.  Type 1 allergic reactions to plant-derived food: a consequence of primary sensitization to pollen allergens. , 1996, The Journal of allergy and clinical immunology.

[44]  M. Chapman,et al.  Reduction in IgE binding to allergen variants generated by site-directed mutagenesis: contribution of disulfide bonds to the antigenic structure of the major house dust mite allergen Der p 2. , 1996, Molecular immunology.

[45]  R. Valenta,et al.  Recombinant allergens for diagnosis and therapy of allergic diseases. , 1995, Current opinion in immunology.

[46]  R. Valenta,et al.  Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). , 1995, The Journal of allergy and clinical immunology.

[47]  H. Breiteneder,et al.  T cell clones specific for Bet v I, the major birch pollen allergen, crossreact with the major allergens of hazel, Cor a I, and alder, Aln g I. , 1993, Molecular immunology.

[48]  J. Greenstein,et al.  Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[49]  H. Metzger,et al.  Signal transduction by Fc receptors: the Fc&RI case , 1993 .

[50]  R. Valenta,et al.  Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. , 1991, The Journal of allergy and clinical immunology.

[51]  R. Valenta,et al.  Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. , 1991, Science.

[52]  R. Valenta,et al.  The gene coding for the major birch pollen allergen Betv1, is highly homologous to a pea disease resistance response gene. , 1989, The EMBO journal.

[53]  H. Ipsen,et al.  Immunotherapy with partially purified and standardized tree pollen extracts , 1988, Allergy.

[54]  H. Ipsen,et al.  Immunotherapy with partially purified and standardized tree pollen extracts , 1988, Allergy.

[55]  L. Lichtenstein,et al.  Studies on allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. , 1981, The Journal of allergy and clinical immunology.

[56]  N. Chiorazzi,et al.  Immunological properties of conjugates of ragweed pollen antigen E with methoxypolyethylene glycol or a copolymer of D-glutamic acid and D- lysine , 1979, The Journal of experimental medicine.

[57]  L. Lichtenstein,et al.  Studies on "allergoids" prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component. , 1970, Immunology.

[58]  Jules Freund,et al.  Sensitization and Antibody Formation after Injection of Tubercle Bacilli and Paraffin Oil.∗ , 1937 .

[59]  L. Noon.  Prophylactic inoculation against hay fever. , 1911, International archives of allergy and applied immunology.

[60]  A. Hall.  THE SATELLITES OF MARS. , 1881, Science.

[61]  A. Kaplan,et al.  Allergy and allergic diseases. , 2008 .

[62]  A. Kagey‐Sobotka,et al.  215 Immunostimulatory oligonucleotides conjugated to Amb a 1: Safety, skin test reactivity, and basophil histamine release , 2000 .

[63]  K. Hoffmann‐Sommergruber,et al.  Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. , 2000, The Journal of allergy and clinical immunology.

[64]  S. Spitzauer,et al.  Allergy review series II : Recombinant allergens , 1998 .

[65]  R. Valenta,et al.  Diagnosis of grass pollen allergy with recombinant timothy grass (Phleum pratense) pollen allergens. , 1992, International archives of allergy and immunology.

[66]  A. Sehon.  Carl Prausnitz Memorial Lecture. Suppression of antibody responses by chemically modified antigens. , 1991, International archives of allergy and applied immunology.

[67]  H. Vik,et al.  Comparative studies on tree pollen allergens. XVII. Immunochemical analysis of the international standardization extracts of birch (Betula verrucosa) pollen as compared with a local partially purified extract. , 1987, Annals of allergy.

[68]  K. Kalimo,et al.  Cross-reactivity of IgE antibodies with allergens in birch pollen, fruits and vegetables. , 1984, International archives of allergy and applied immunology.